Disposable bronchoscopes such as the Ambu aScope TM 3 are marketed as 'single use' The risks of contamination from prolonged device storage before possible re-use are unknown. Following clinical bronchoscopy in patients whose lungs were mechanically ventilated, 20 aScope TM 3's bronchoscopes received a standard 'social clean' and were then stored. Subsequent paired saline flush and swab samples were taken at time zero, and at 24 h and 48 h. Positive microbiological cultures were obtained from at least one time point from 16 of the 20 bronchoscopes. Pathogens considered at high risk of causing pneumonia were isolated from seven bronchoscopes, with significant quantities from six of them. Our study demonstrates that aScope TM 3's should not be re-used on the same patient, as clinically significant growth of micro-organisms occurs frequently, despite adequate social cleaning. Culture of bronchoscopes themselves may be a potentially useful diagnostic tool in the context of pulmonary infection. Our data make it clear that these devices are single use and not single patient use.
Introduction
Bronchoscopy is a common diagnostic and therapeutic procedure on the ICU. Diagnostic uses include aspiration of sputum or cytology samples for microbiological or pathological analysis. Sample aspiration may be facilitated by first instilling small volumes of saline (typically 20 ml) during either a bronchial wash, or a more formal broncho-alveolar lavage (BAL), which involves instilling and aspirating 50-200 ml of saline from a lung segment. Bronchial washing may also be used as a therapeutic manoeuvre for lobar collapse, by the removal of mucus plugs or secretions.
Relatively complex, re-useable flexible bronchoscopes are typically used for these procedures, and cleaning is followed by sterilisation or high-level disinfection with rinsing and drying before storage. Bronchoscopes are at a greater risk of residual contamination due to their relatively small working channel size when compared with devices such as gastroscopes. Exogenous micro-organisms may be transmitted by bronchoscopes by contamination of reprocessing equipment, of the bronchoscopes themselves, or of accessory equipment. Although relatively rare, 48 outbreaks of exogenous bronchoscopy-related infections and cross-contaminations involving 198 infected patients were reported in the literature between 1970 and 2012, and the problem is likely to be under-reported [1, 2] . Outbreaks of bronchoscopyrelated transmission of multidrug-resistant Pseudomonas aeruginosa and carbapenemase-producing Klebsiella pneumoniae have also been published, along with news reports of cross-contamination [3] [4] [5] [6] [7] [8] . This led the US Food and Drug Administration to publish a safety communication in September 2015 highlighting contamination of re-usable bronchoscopes [9] , and to the ECRI Institute (Emergency Care Research Institute) declaring 'Inadequate cleaning of flexible endoscopes before disinfection can spread deadly pathogens' as the top Health Technology Hazard for 2016 [10] . 
Methods
The NHS Health Research Authority online tool determined that this study did not require formal ethical approval, but the study was subject to local internal research governance procedures. The University Hospital South Manchester has a mixed tertiary ICU with 17 beds, managing a wide range of adult patients. Surgical specialties supported include major vascular, general and upper gastrointestinal surgery, orthopaedics and trauma, major urology, burns, plastic surgery, and head and neck surgery. The unit admits mixed medical patients, and the hospital also houses the North-West Lung Centre and infectious diseases department, including the National Aspergillus Centre.
Unselected patients whose lungs were ventilated underwent bronchoscopy at the discretion of the attending clinicians. The ICU stocks a mixture of single-use aScope TM 3's and re-useable bronchoscopes, and device choice was left entirely to the operator. If an aScope TM 3 was used between Monday and Wednesday (when research staff were available to perform subsequent sampling and analysis for the following 48 h), the device was quarantined following use and studied. The used bronchoscope was exposed to a standard 'social clean' by research staff. This comprised flushing the working channel with 20 ml of sterile saline, followed by external decontamination with our ICU standard proprietary non-enzymatic detergent fluid and pre-packed sponge (UNO-FLUSH â Endoscope Channel Cleanser; Medical Innovations Group, Essex, UK). The bronchoscope was then flushed with a further 20 ml of sterile saline, and this fluid was collected for microbiological analysis. The tip of the endoscope was swabbed using our standard sample medium swabs (CultureSwab TM ; Becton Dickinson Company â , Oxford, UK) and these were also sent for analysis. Paired flush and swab samples were taken at time zero (immediately following social clean after use), at 24 h and at 48 h. This allowed research staff to complete the analysis within the working week following use. We collected samples within a 2-h window; 1 h either side of the time of the first clinical use of the bronchoscope.
The aScope TM 3's were stored between sampling in their original packaging on the ICU at room temperature. We anonymised and recorded the results of any microbiological samples taken from the patient at the time of the original clinical bronchoscopy at 48 h. This observational study did not influence the clinical management of the patient, and contemporaneous clinical microbiological samples were taken from the patient via bronchoscopy only if the attending clinician felt this was clinically indicated. No other potential clinical, laboratory or radiological markers of infection were collected. We recorded bacterial colony count and identification for each positive patient or bronchoscope sample. Isolates were classified using a Red-Amber-Green (RAG) coding system to indicate high, intermediate or low risk, respectively, for causing hospital-acquired pneumonia or ventilator-acquired pneumonia in our ICU patients. The RAG coding system is used by microbiologists at our hospital based on our local microbiological profiles, and knowledge of which organisms are most likely to cause invasive pulmonary infections in our critically ill patients.
Results
We obtained microbiological results from 20 aScope TM 3's. All intended flush and swab samples were acquired within the specified timeframe, and we undertook analysis of 60 swab and 60 flush samples. Positive microbiological cultures were obtained in either swab or flush specimens from 16 of the 20 bronchoscopes at some point in the 48 h following social clean. These included 11 bronchoscopes with positive flush samples, seven with positive swab samples and five where both flush and swab samples were positive. At time zero, sufficient quantities of pathogens considered to be at high risk of causing pneumonia were isolated from 4/20 bronchoscopes, with organisms considered medium risk isolated from a further 4/20. Over 48 h, a total of seven bronchoscopes (35%) had pathogens isolated from them considered at high risk of causing pneumonia, and on six occasions, these were present in significant quantities at 48 h. Table 1 outlines the organisms isolated and the significance associated using the RAG rating scheme.
There were 15 episodes of bronchoscope use that were associated with contemporaneous microbiological sampling for clinical reasons. There was no organism identified in seven of these samples after routine incubation and analysis. Of the remaining eight positive clinical cultures, the same organism was grown from the bronchoscope samples on five occasions. One bronchoscope grew a different organism to that identified from paired clinical sampling. In four bronchoscopes, all flush and swab samples were negative for any growth; two of these bronchoscope uses were associated with positive clinical microbiology, with no contemporaneous clinical samples taken during the other two uses.
Discussion
Our results indicate that prolonged bedside storage of bronchoscopes following clinical use and social cleaning may encourage microbiological growth of organisms implicated in causing pneumonia. This finding is not surprising, but is relevant to situations where a used endoscope could be stored and potentially re-used on the same patient. Following social cleaning at time zero, four bronchoscopes unexpectedly grew organisms considered to be high risk for causing pneumonia in critical care populations. Worryingly, two bronchoscopes isolated Pseudomonas aeruginosa, a highly successful opportunistic pathogen associated with a wide spectrum of conditions including nosocomial pneumonia, blood stream and respiratory infections. In both of these cases there was concordance with the clinical patient samples, suggesting contamination from the bronchoscopic procedure. With the colony counts increasing significantly over the 48 h of storage, this could infer that the social clean undertaken was not sufficient to prevent colonisation. Our intention was not to sterilise the bronchoscopes after use, but to apply a recognised form of physical and enzymatic Non-HS, non-haemolytic streptococcus; AHS, alpha-hemolytic streptococci; MC, micrococcus; C alb, Candida albicans; CNS, coagulase negative staphylococci; E coli, Escherichia coli; ASB, aerobic spore bearer; Ps.ory, Pseudomonas oryzihabitan; S aur, Staphylococcus aureus; E cloa, Enterobacter cloacae; Ps aer, Pseudomonas aeruginosa; H flu, Haemophilus influenzae; Kleb oxy, Klebsiella Oxytoca; Kleb pne, Klebsiella pneumoniae. Key to bacterial colonies.ml À1 +: < 100 colonies.ml À1 . ++: > 100 colonies.ml À1 but < 1000 colonies.ml À1 . +++: > 1000 colonies.ml À1 but < 10,000 colonies.ml À1 . ++++: > 10,000 colonies.ml À1 but < 100,000 colonies.ml À1 . +++++: > 100,000 colonies.ml À1 . RAG: clinical significance rating. R: Red Organisms known to cause pneumonia. A: Amber Organisms that can in certain circumstances cause pneumonia. G: Green Organisms where there is little or no evidence that these organism would pneumonia.
cleaning that would not preclude potential clinical reuse. A stronger antibacterial agent could be a source of potential harm to the patient if re-introduced into patient's airways, and could damage the integrity of the bronchoscopes itself. The aScope TM 3's are not designed to tolerate standard decontamination treatments that non-disposable bronchoscopes are subjected to. We isolated organisms considered to be intermediate risk for respiratory infection from four bronchoscopes. Viridans streptococci are commensals of the respiratory tract, but under certain situations, such as in neutropaenic patients, can become invasive and cause pneumonia. Candida albicans is not considered to be a pathogen in isolation, but may encourage biofilm formation and therefore colonisation with other known pathogens such as Pseudomonas aeruginosa. Paired clinical samples were only collected for two of these bronchoscopes, but in one of these, the clinical isolate was identical (Candida albicans).
By 24 h following clinical use, pathogens considered to be high risk (Staph aureus and Klebsiella pneumonia) had been isolated from a further two bronchoscopes. Klebsiella is an important nosocomial and opportunistic pathogen that is known to cause bronchopneumonia. Although Staph aureus can be a coloniser of the upper respiratory tract, it can also cause primary and secondary pneumonia. By 48 h following use, six bronchoscopes remained colonised with high-risk pathogens; re-using these colonised bronchoscopes in the immunosuppressed or critically ill would put patients at increased risk for nosocomial infection by contributing to an increased bioburden.
Cross-contamination has been reported with reuseable bronchoscopes. The exogenous micro-organisms most frequently associated with transmission of infection during bronchoscopy are Pseudomonas aeruginosa and mycobacteria [11] . The most common factor associated with microbial transmission is inadequate cleaning and disinfection, identified in up to 60% of outbreaks [1] . Reported outbreaks were frequently related to inadequate manual cleaning and brushing, use of contaminated endoscope accessories, use of inappropriate disinfectants with low and intermediate potency, and resistance of micro-organisms to disinfectants. Around one-third of outbreaks were associated with a contaminated or defective endoscope reprocessor, with a further third associated with inadequate drying and storage. There is also variation and inconsistency between reprocessing guidelines [12, 13] . The potential for iatrogenic harm to multiple patients from contaminated bronchoscopes has led some authors to suggest additional cleaning measures, and that routine pre-use 'control' BAL samples should be taken before clinical use of a re-usable bronchoscope [12, 14] . This approach could alert departments that a scope is contaminated, and also ensure that positive clinical samples are true positives, preventing unnecessary treatment.
Of interest, seven bronchoscopes grew microorganisms that did not grow in paired patient samples. One possible explanation for this could be that the bronchoscopes themselves provide a good environment for sampled micro-organisms to grow. Bedside storage in the original packaging may also have encouraged growth, but this was intentionally done to mirror the likely storage conditions of a used aScope TM 3's before potential re-use. The bronchoscopes were all introduced via tracheal or tracheostomy tubes, and the micro-organisms isolated from the bronchoscopes may simply represent the biofilm within these airway devices. This observational study did not routinely collect paired clinical samples from all potential sources such as blood, sputum and BAL, and so it is possible that clinical infection was simply not detected. Our study did not consider other potential identifiers of clinical infection such as pneumonia scoring systems or X-ray interpretation. Although we did not actively investigate whether the detected micro-organisms were directly associated with clinical infection, identification of pathogen colonies considered locally to be at high risk of causing subsequent infection is likely to be of clinical significance, especially in the critical care population undergoing invasive mechanical ventilation. However, given the difficulty in detecting and identifying micro-organisms responsible for critical illness using standard sampling and culture techniques, even using validated multivariable scoring systems, prolonged storage and culture of bronchoscopes following use may be of diagnostic benefit [15] . Cross-contamination following bronchoscopic procedures due to exogenous micro-organisms that are not adequately removed during reprocessing has been widely reported. Single-use devices such as the aScope TM 3 eliminate the risk of cross-contamination, and these devices may be cost-effective for certain services [16] . Our study demonstrates that aScope TM 3's should not be re-used on the same patient, as clinically significant growth of micro-organisms frequently occurs despite adequate social cleaning. Further work should evaluate the clinical significance of pathogens isolated from single-use bronchoscopes at intervals less than 24 h. Culture of bronchoscopes themselves may be a potentially useful diagnostic tool in the context of pulmonary infection. Our data make it clear that these devices are single use and not single patient use.
